BIOMAT Database Logo BIOMAT Database Logo

HLA-mismatched allogeneic bone marrow transplantation. 1987

C H Tzeng, and P M Chen, and C F Chiu, and T J Chiou, and R K Hsien, and M W Chuang, and K Y Chen, and C H Yung, and S Y Wang, and S R Wang

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006648 Histocompatibility The degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts. HLA Incompatibility,Histoincompatibility,Human Leukocyte Antigen Incompatibility,Immunocompatibility,Tissue Compatibility,Compatibility, Tissue,HLA Incompatibilities,Histocompatibilities,Histoincompatibilities,Immunocompatibilities,Incompatibility, HLA,Tissue Compatibilities
D006681 HLA-D Antigens Human immune-response or Class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology. Antigens, HLA-D,Class II Human Antigens,HLA-Dw Antigens,Human Class II Antigens,Ia-Like Antigens, Human,Immune Response-Associated Antigens, Human,Immune-Associated Antigens, Human,Immune-Response Antigens, Human,HLA-D,HLA-Dw,Immune Response Associated Antigens, Human,Antigens, HLA D,Antigens, HLA-Dw,Antigens, Human Ia-Like,Antigens, Human Immune-Associated,Antigens, Human Immune-Response,HLA D Antigens,HLA Dw Antigens,Human Ia-Like Antigens,Human Immune-Associated Antigens,Human Immune-Response Antigens,Ia Like Antigens, Human,Immune Associated Antigens, Human,Immune Response Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C H Tzeng, and P M Chen, and C F Chiu, and T J Chiou, and R K Hsien, and M W Chuang, and K Y Chen, and C H Yung, and S Y Wang, and S R Wang
[HLA-mismatched bone marrow transplantation].
September 1990, Nihon rinsho. Japanese journal of clinical medicine,
C H Tzeng, and P M Chen, and C F Chiu, and T J Chiou, and R K Hsien, and M W Chuang, and K Y Chen, and C H Yung, and S Y Wang, and S R Wang
HLA-mismatched bone marrow transplantation.
November 1992, Transplantation,
C H Tzeng, and P M Chen, and C F Chiu, and T J Chiou, and R K Hsien, and M W Chuang, and K Y Chen, and C H Yung, and S Y Wang, and S R Wang
HLA-mismatched bone marrow transplantation in thalassemia.
January 1991, Bone marrow transplantation,
C H Tzeng, and P M Chen, and C F Chiu, and T J Chiou, and R K Hsien, and M W Chuang, and K Y Chen, and C H Yung, and S Y Wang, and S R Wang
HLA-mismatched bone marrow transplantation in thalassemia.
January 1993, Bone marrow transplantation,
C H Tzeng, and P M Chen, and C F Chiu, and T J Chiou, and R K Hsien, and M W Chuang, and K Y Chen, and C H Yung, and S Y Wang, and S R Wang
[HLA serologically mismatched unrelated bone marrow transplantation].
July 2006, [Rinsho ketsueki] The Japanese journal of clinical hematology,
C H Tzeng, and P M Chen, and C F Chiu, and T J Chiou, and R K Hsien, and M W Chuang, and K Y Chen, and C H Yung, and S Y Wang, and S R Wang
Lung toxoplasmosis after HLA mismatched bone marrow transplantation.
September 1994, Bone marrow transplantation,
C H Tzeng, and P M Chen, and C F Chiu, and T J Chiou, and R K Hsien, and M W Chuang, and K Y Chen, and C H Yung, and S Y Wang, and S R Wang
Allogeneic bone marrow transplantation with non-T-cell-depleted marrow from two HLA-antigen-mismatched related donors.
March 2004, Haematologica,
C H Tzeng, and P M Chen, and C F Chiu, and T J Chiou, and R K Hsien, and M W Chuang, and K Y Chen, and C H Yung, and S Y Wang, and S R Wang
HLA-mismatched bone marrow transplantation in severe aplastic anemia.
September 2017, Bone marrow transplantation,
C H Tzeng, and P M Chen, and C F Chiu, and T J Chiou, and R K Hsien, and M W Chuang, and K Y Chen, and C H Yung, and S Y Wang, and S R Wang
HLA-DP and allogeneic bone marrow transplantation.
June 1994, Bone marrow transplantation,
C H Tzeng, and P M Chen, and C F Chiu, and T J Chiou, and R K Hsien, and M W Chuang, and K Y Chen, and C H Yung, and S Y Wang, and S R Wang
Inadvertent completely HLA-mismatched allogeneic unrelated bone marrow transplant: lessons learned.
July 2016, Bone marrow transplantation,
Copied contents to your clipboard!